LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

Search

Axonics Inc

Closed

Sector Healthcare

67.41 0.19

Overview

Share price change

24h

Current

Min

67

Max

67.76

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+5.53 upside

Dividends

By Dow Jones

Next Earnings

25 lip 2024

News Sentiment

By Acuity

50%

50%

124 / 370 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Axonics Inc Chart

Related News

8 sty 2024, 16:21 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Axonics Shares Climb 20% After Acquisition by Boston Scientific

8 sty 2024, 12:26 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific To Acquire Axonics For About $3.7 Billion

8 sty 2024, 15:59 UTC

Acquisitions, Mergers, Takeovers

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot' -- IBD

8 sty 2024, 14:19 UTC

Acquisitions, Mergers, Takeovers

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value -- IBD

8 sty 2024, 13:18 UTC

Acquisitions, Mergers, Takeovers

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal. -- Barrons.com

8 sty 2024, 12:12 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Acquisition Impact to GAAP EPS Expected to Be Less Accretive, or More Dilutive, Due to Amortization Expense and Acquisition-Related Net Charges >BSX

8 sty 2024, 12:12 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Sees Acquisition Impact to Adj EPS Immaterial in 2024 and Accretive Thereafter >BSX

8 sty 2024, 12:11 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Axonics' Rev Growth Profile Is Anticipated to Be Highly Accretive to BSX Urology Business in 2024 >BSX

8 sty 2024, 12:11 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Axonics Expects to Deliver Net Rev of About $366 M in 2023 >BSX

8 sty 2024, 12:11 UTC

Top News
Acquisitions, Mergers, Takeovers

Boston Scientific To Acquire Axonics For About $3.7 Bln

8 sty 2024, 12:10 UTC

Acquisitions, Mergers, Takeovers

Axonic's Stock Soars After Cash Buyout Deal With Boston Scientific Valued At $3.7 Billion -- MarketWatch

8 sty 2024, 12:02 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Deal Reflects Equity Value of About $3.7B and Enterprise Value of About $3.4B

8 sty 2024, 12:02 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Acquisition to Expand Urology Portfolio With Differentiated Technologies to Treat Urinary and Bowel Dysfunction >BSX

8 sty 2024, 12:02 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX

8 sty 2024, 12:01 UTC

Acquisitions, Mergers, Takeovers

Axonics to Be Acquired for $71/Share; Closed Friday at $57.57 >BSX AXNX

8 sty 2024, 12:01 UTC

Acquisitions, Mergers, Takeovers

Axonics to Be Acquired by Boston Scientific for About $3.7 Billion >BSX AXNX

8 sty 2024, 12:01 UTC

Acquisitions, Mergers, Takeovers

Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX

8 sty 2024, 12:00 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Announces Agreement To Acquire Axonics, Inc. >BSX AXNX

8 sty 2024, 12:00 UTC

Acquisitions, Mergers, Takeovers

Axonics Announces Definitive Agreement To Be Acquired By Boston Scientific >AXNX BSX

Peer Comparison

Price change

Axonics Inc Forecast

Price Target

By TipRanks

5.53% upside

12 Months Forecast

Average 71 USD  5.53%

High 71 USD

Low 71 USD

Based on 3 Wall Street analysts offering 12 month price targets forAxonics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

3 ratings

0

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

67.19 / 67.38Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

124 / 370 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average